GlaxoSmithKline in $150 Million Settlement in Generic Nasal Spray Case -Reuters
12/19/2012| 01:31pm US/Eastern
GlaxoSmithKline PLC (>> GlaxoSmithKline plc) has agreed to a $150 million settlement with a group of drug wholesalers who claimed the drug maker delayed the introduction of generic alternatives to Flonase nasal spray, Reuters reported Wednesday, citing court documents.
AmerisourceBergen Corp. (>> AmerisourceBergen Corp.), Cardinal Health Inc. (>> Cardinal Health, Inc.) and McKesson Corp. (>> McKesson Corporation) were among the companies reaching the preliminary settlement, approved by the U.S. District Court for the Eastern District of Pennsylvania.
Full story at: www.reuters.com/article/2012/12/19/glaxosmithkline-settlement-idUSL1E8NJ8NP20121219
Write to firstname.lastname@example.org
Subscribe to WSJ: http://online.wsj.com?mod=djnwires